Tagraxofusp, CAS 2055491-00-2

Product Description: Tagraxofusp (SL-401) is a potent IL-3 receptor inhibitor to inhibits plasmacytoid dendritic cells (pDCs) growth in multiple myeloma (MM) bone marrow (BM) microenvironment. Tagraxofusp has synergistic effect with Bortezomib (HY-10227) and Pomalidomide (HY-10984) to suppress multiple myeloma (MM)[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Ray A, et al. A novel agent SL-401 induces anti-myeloma activity by targeting plasmacytoid dendritic cells, osteoclastogenesis and cancer stem-like cells. Leukemia. 2017 Dec;31(12):2652-2660.

CAS Number: 2055491-00-2

Molecular Weight: N/A

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Interleukin Related

• Artikelnummer: MEXHY-P99536-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99536-5
• Green Labware: Nein
• Verpackungseinheit: 5mg
• Mengeneinheit: STK